Movatterモバイル変換


[0]ホーム

URL:


DK3060239T3 - LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION - Google Patents

LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION
Download PDF

Info

Publication number
DK3060239T3
DK3060239T3DK14856666.4TDK14856666TDK3060239T3DK 3060239 T3DK3060239 T3DK 3060239T3DK 14856666 TDK14856666 TDK 14856666TDK 3060239 T3DK3060239 T3DK 3060239T3
Authority
DK
Denmark
Prior art keywords
policptides
submission
manufacture
term
methods
Prior art date
Application number
DK14856666.4T
Other languages
Danish (da)
Inventor
Fuad Fares
Udi Eyal Fima
Original Assignee
Opko Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/059,134external-prioritypatent/US20140113860A1/en
Priority claimed from US14/309,496external-prioritypatent/US20150038413A1/en
Application filed by Opko Biologics LtdfiledCriticalOpko Biologics Ltd
Application grantedgrantedCritical
Publication of DK3060239T3publicationCriticalpatent/DK3060239T3/en

Links

Classifications

Landscapes

DK14856666.4T2013-10-212014-10-21 LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSIONDK3060239T3 (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US14/059,134US20140113860A1 (en)2006-02-032013-10-21Long-acting polypeptides and methods of producing and administering same
US14/309,496US20150038413A1 (en)2006-02-032014-06-19Long-acting polypeptides and methods of producing and administering same
PCT/IL2014/050910WO2015059695A1 (en)2013-10-212014-10-21Long-acting polypeptides and methods of producing and administering same

Publications (1)

Publication NumberPublication Date
DK3060239T3true DK3060239T3 (en)2020-08-03

Family

ID=52992360

Family Applications (1)

Application NumberTitlePriority DateFiling Date
DK14856666.4TDK3060239T3 (en)2013-10-212014-10-21 LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION

Country Status (21)

CountryLink
EP (2)EP3763733A1 (en)
JP (3)JP6640720B2 (en)
KR (4)KR20220130254A (en)
CN (1)CN106163543A (en)
AU (3)AU2014338575B2 (en)
CA (1)CA2928269C (en)
DK (1)DK3060239T3 (en)
ES (1)ES2811068T3 (en)
FR (1)FR22C1035I2 (en)
HR (1)HRP20201114T1 (en)
HU (2)HUE050002T2 (en)
IL (1)IL297219B2 (en)
LU (1)LUC00259I2 (en)
MX (2)MX381148B (en)
NL (1)NL301170I2 (en)
PL (1)PL3060239T3 (en)
PT (1)PT3060239T (en)
RU (1)RU2746943C2 (en)
SI (1)SI3060239T1 (en)
TW (4)TW201536312A (en)
WO (1)WO2015059695A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DK3060239T3 (en)2013-10-212020-08-03Opko Biologics Ltd LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION
JOP20190019A1 (en)2016-08-302019-02-12Genexine Inc Pharmaceutical Formula for Treatment of Growth Hormone Deficiency Contains Human Growth Hormone (hGH) Fusion Protein
CN109942717A (en)*2019-04-242019-06-28上海延立药业有限公司A kind of long-acting recombinant human follicle-stimulating hormone (FSH) and its preparation method and application
IL305661A (en)*2021-03-192023-11-01PfizerMethods of administering long-acting growth hormone polypeptides

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
NL154600B (en)1971-02-101977-09-15Organon Nv METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
NL154598B (en)1970-11-101977-09-15Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
NL154599B (en)1970-12-281977-09-15Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
US3901654A (en)1971-06-211975-08-26Biological DevelopmentsReceptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en)1971-09-011974-12-10W DreyerImmunological reagent and radioimmuno assay
US3867517A (en)1971-12-211975-02-18Abbott LabDirect radioimmunoassay for antigens and their antibodies
NL171930C (en)1972-05-111983-06-01Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3850578A (en)1973-03-121974-11-26H McconnellProcess for assaying for biologically active molecules
US3935074A (en)1973-12-171976-01-27Syva CompanyAntibody steric hindrance immunoassay with two antibodies
US3996345A (en)1974-08-121976-12-07Syva CompanyFluorescence quenching with immunological pairs in immunoassays
US4034074A (en)1974-09-191977-07-05The Board Of Trustees Of Leland Stanford Junior UniversityUniversal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en)1975-11-131976-10-05General Electric CompanyElectrophoretic method of detecting antigen-antibody reaction
US4098876A (en)1976-10-261978-07-04Corning Glass WorksReverse sandwich immunoassay
US4879219A (en)1980-09-191989-11-07General Hospital CorporationImmunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en)1984-04-121991-04-30The General Hospital CorporationMultiepitopic immunometric assay
DE3421468A1 (en)1984-06-081985-12-19Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
US4666828A (en)1984-08-151987-05-19The General Hospital CorporationTest for Huntington's disease
US4683202A (en)1985-03-281987-07-28Cetus CorporationProcess for amplifying nucleic acid sequences
US4801531A (en)1985-04-171989-01-31Biotechnology Research Partners, Ltd.Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
DE3751873T2 (en)1986-04-091997-02-13Genzyme Corp Genetically transformed animals that secrete a desired protein in milk
US4873316A (en)1987-06-231989-10-10Biogen, Inc.Isolation of exogenous recombinant proteins from the milk of transgenic mammals
ATE110571T1 (en)1988-05-061994-09-15Toray Industries STABLE INTERFERON BETA COMPOSITION.
US5272057A (en)1988-10-141993-12-21Georgetown UniversityMethod of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
ES2098261T3 (en)1989-02-211997-05-01Univ Washington MODIFIED FORMS OF REPRODUCTIVE HORMONES.
US5464764A (en)1989-08-221995-11-07University Of Utah Research FoundationPositive-negative selection methods and vectors
US5192659A (en)1989-08-251993-03-09Genetype AgIntron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en)1992-07-201994-01-25The Trustees Of The University Of PennsylvaniaModified avidin-biotin technique
US5541110A (en)1994-05-171996-07-30Bristol-Myers SquibbCloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US8946155B2 (en)*2006-02-032015-02-03Opko Biologics Ltd.Long-acting polypeptides and methods of producing and administering same
US8048849B2 (en)*2006-02-032011-11-01Modigene, Inc.Long-acting polypeptides and methods of producing same
US8476234B2 (en)*2006-02-032013-07-02Prolor Biotech Inc.Long-acting coagulation factors and methods of producing same
US7553940B2 (en)*2006-02-032009-06-30Modigene IncLong-acting EPO polypeptides and derivatives thereof and methods thereof
US8304386B2 (en)*2006-02-032012-11-06Prolor Biotech, Inc.Long-acting growth hormone and methods of producing same
US8450269B2 (en)*2006-02-032013-05-28Prolor Biotech Ltd.Long-acting growth hormone and methods of producing same
US20140113860A1 (en)2006-02-032014-04-24Prolor Biotech Ltd.Long-acting polypeptides and methods of producing and administering same
DE102007006189B4 (en)*2007-02-072009-07-30Isotopen Technologien München AG Apparatus for filling a medical instrument with a radioactive substance and method
DK3060239T3 (en)2013-10-212020-08-03Opko Biologics Ltd LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION

Also Published As

Publication numberPublication date
EP3060239B1 (en)2020-05-13
JP2022088521A (en)2022-06-14
IL297219A (en)2022-12-01
MX381148B (en)2025-03-12
MX2016005227A (en)2016-08-12
KR20160068969A (en)2016-06-15
AU2014338575B2 (en)2019-11-07
MX2021003908A (en)2021-06-23
FR22C1035I1 (en)2022-09-09
KR20240110069A (en)2024-07-12
RU2016119565A3 (en)2019-01-22
JP2020073541A (en)2020-05-14
AU2020200874A1 (en)2020-02-27
AU2022246472B2 (en)2025-08-14
TW202120120A (en)2021-06-01
LUC00259I2 (en)2025-04-25
AU2022246472A1 (en)2022-11-10
CN106163543A (en)2016-11-23
IL297219B1 (en)2023-10-01
FR22C1035I2 (en)2024-02-16
EP3060239A4 (en)2017-05-31
TWI777407B (en)2022-09-11
CA2928269C (en)2023-03-14
AU2014338575A1 (en)2016-06-02
JP2016535015A (en)2016-11-10
TWI720940B (en)2021-03-11
RU2021110927A3 (en)2021-12-08
TW201536313A (en)2015-10-01
TW201536312A (en)2015-10-01
NL301170I2 (en)2022-06-16
EP3060239A1 (en)2016-08-31
RU2021110927A (en)2021-05-21
JP7445695B2 (en)2024-03-07
PL3060239T3 (en)2020-11-02
SI3060239T1 (en)2020-10-30
KR102444140B1 (en)2022-09-15
WO2015059695A1 (en)2015-04-30
HUS2200014I1 (en)2022-05-28
RU2746943C2 (en)2021-04-22
KR20220130254A (en)2022-09-26
RU2016119565A (en)2018-11-02
TW202317176A (en)2023-05-01
KR20210118490A (en)2021-09-30
TW201536327A (en)2015-10-01
NL301170I1 (en)2022-04-29
HUE050002T2 (en)2020-11-30
HRP20201114T1 (en)2020-10-30
PT3060239T (en)2020-08-26
IL297219B2 (en)2024-02-01
EP3763733A1 (en)2021-01-13
ES2811068T3 (en)2021-03-10
CA2928269A1 (en)2015-04-30
JP7051797B2 (en)2022-04-11
TWI720939B (en)2021-03-11
JP6640720B2 (en)2020-02-05

Similar Documents

PublicationPublication DateTitle
DK3019200T3 (en) OLIGONUCLEOTIDE-LIGAND CONJUGATES AND METHOD OF PREPARATION
DK2961831T3 (en) Compositions and methods of immunotherapy
DK3317284T3 (en) Benzoxazepine-oxazolidinone compounds and methods of use
DK3087095T3 (en) FcRn antagonist and methods of use
DK3043784T3 (en) ARYLETES AND USES THEREOF
DK3086807T3 (en) Antibodies and methods of use
DK3009021T3 (en) Glove and method of making it
DK3053071T3 (en) METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
DK2968443T3 (en) HEPCIDINE ANALOGS AND USES THEREOF
DK2872153T3 (en) ACCELLULAR PRO-TOLEROGENIC COMPOSITIONS AND METHOD OF MANUFACTURE
DK3049056T4 (en) TOPICAL ANTIFUNGAL COMPOSITIONS AND METHODS OF TREATMENT
DK3003039T3 (en) METHYL / FLUOR-PYRIDINYL-METOXY-SUBSTITUTED PYRIDINON-PYRIDINYL-COMPOUNDS AND FLUOR-PYRIMIDINYL-METOXY-SUBSTITUTED PYRIDINON-PYRIDINYL-CONNECTIONS
DK3063144T3 (en) ANTIPARASITARY AND PESTICID-ISOXAZOLINE COMPOUNDS
DK2962100T3 (en) TUBERCULOSEBIOMARKEARS AND USES THEREOF
DK3074544T3 (en) Martensite-containing stainless steel, piece made of this steel and method of manufacture thereof
DK3076972T3 (en) CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXAN
DK3003117T3 (en) VIDEOLARYNGOSCOPE AND LARYNGOSCOPE INTRODUCTION
DK3077467T3 (en) SIKKATIVE COMPOSITION AND USE THEREOF
DK3082902T3 (en) BODY-BORED INJECTOR AND METHOD OF USE
DK3067355T3 (en) CRYSTALS OF DIAZABICYCLOOCTAN DERIVATIVES AND METHOD OF MANUFACTURE OF CRYSTALS OF DIAZABICYCLOOCTAN DERIVATIVES
DK3089971T3 (en) Compounds and methods of use
DK3394430T3 (en) WIND TURBLE WINGS AND ASSOCIATED METHODS OF MANUFACTURE
DK3030549T3 (en) PYRIDAZINON COMPOUNDS AND USES THEREOF
DK3010995T3 (en) METHOD OF MANUFACTURE OF BIODIESEL AND RELATED PRODUCTS
DK2964767T3 (en) TOXICATIONS AND PROCEDURES FOR USE THEREOF

[8]ページ先頭

©2009-2025 Movatter.jp